FDA expands Pfizer boosters for more teens as omicron surges-
By PTI WASHINGTON: The US is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug […]
fda
FDA close to booster authorization for kids 12-15: report
The U.S. Food and Drug Administration (FDA) is reportedly planning to expand eligibility for COVID-19 vaccine booster shots on Monday. The
White House team reacts to FDA report on rapid COVID test sensitivity: PCR, antigen tests ‘critical tools’
Members of the White House COVID-19 response team reacted Wednesday to new guidance from the Food and Drug Administration (FDA)
FDA faces legal challenge over COVID-19 approval data, report says
A nonprofit group will get its day in court Tuesday when it argues that the Food and Drug Administration should
FDA authorizes AstraZeneca COVID antibody treatment for emergency use
The U.S. Food and Drug Administration on Wednesday issued emergency use authorization for AstraZeneca’s Evusheld. The vaccine maker’s COVID-19 antibody drug
FDA expands Pfizer COVID booster, opens extra dose to age 16
The U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine.The U.S.
FDA panel endorses first COVID-19 pill
A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage
Amid Omicron threat, FDA panel backs first-of-a-kind COVID-19 pill from Merck-
By PTI WASHINGTON: A panel of US health advisers narrowly backed the benefits of a closely watched COVID-19 pill from
FDA approves ‘glowing tumor’ drug to help surgeons identify ovarian cancer cells
Cytalux (pafolacianince), a drug that binds to ovarian cancer tissue and glows when exposed to fluorescent light, has been approved
Merck COVID-19 pill: FDA panel weighs safety, effectiveness
Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon